VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level.
about
Hallmarks of cancer and AU-rich elementsRole of hypoxia and vascular endothelial growth factors in lymphangiogenesisSkeletal muscle as an endocrine organ: PGC-1α, myokines and exerciseProteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2The translation initiation factor eIF3i up-regulates vascular endothelial growth factor A, accelerates cell proliferation, and promotes angiogenesis in embryonic development and tumorigenesis.RNA-Sequencing data supports the existence of novel VEGFA splicing events but not of VEGFAxxxb isoforms.Relatively frequent switching of transcription start sites during cerebellar development.New Insights into VEGF-A Alternative Splicing: Key Regulatory Switching in the Pathological ProcessIdentification by high-throughput imaging of the histone methyltransferase EHMT2 as an epigenetic regulator of VEGFA alternative splicing.Suppression of laser-induced choroidal neovascularization by intravitreal injection of tristetraprolin.RNA-seq analysis reveals significant effects of EGFR signalling on the secretome of mesenchymal stem cells.CCL5 promotes VEGF-dependent angiogenesis by down-regulating miR-200b through PI3K/Akt signaling pathway in human chondrosarcoma cells.E2F1 suppresses cardiac neovascularization by down-regulating VEGF and PlGF expression.Differential expression and regional distribution of aquaporins in amnion of normal and gestational diabetic pregnanciesAssociation between a vascular endothelial growth factor gene polymorphism (rs2146323) and diabetic retinopathy: a meta-analysisEnhanced Mitogenic Activity of Recombinant Human Vascular Endothelial Growth Factor VEGF121 Expressed in E. coli Origami B (DE3) with Molecular Chaperones.Stabilization of the G-quadruplex at the VEGF IRES represses cap-independent translation.Proteomics and SSH Analyses of ALA-Promoted Fruit Coloration and Evidence for the Involvement of a MADS-Box Gene, MdMADS1Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform.Can we observe changes in mRNA "state"? Overview of methods to study mRNA interactions with regulatory proteins relevant in cancer related processes.VEGFA splicing: divergent isoforms regulate spermatogonial stem cell maintenance.Key contribution of eIF4H-mediated translational control in tumor promotion.Induction of VEGFA mRNA translation by CoCl2 mediated by HuR.Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis.Different cyclical intermittent hypoxia severities have different effects on hippocampal microvasculature.Estrogen deficiency in ovariectomized rats: can resistance training re-establish angiogenesis in visceral adipose tissue?Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors.Angiogenesis in the atherosclerotic plaque.Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy.Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer.Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients.Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis.Vascular endothelial growth factor control mechanisms in skeletal growth and repair.The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer.VEGF-A and VEGFR1 SNPs associate with preeclampsia in a Philippine population.Hypoxia and Hypoglycemia synergistically regulate mRNA stability.VEGF expression correlates with neuronal differentiation and predicts a favorable prognosis in patients with neuroblastomaN6-methyladenosine is required for the hypoxic stabilization of specific mRNAs.Elevated TATA-binding protein expression drives vascular endothelial growth factor expression in colon cancer.MicroRNA-141 and microRNA-146b-5p inhibit the prometastatic mesenchymal characteristics through the RNA-binding protein AUF1 targeting the transcription factor ZEB1 and the protein kinase AKT
P2860
Q26744134-D1B44D0E-15C4-48A2-9FF4-ED732EBA1971Q26745683-F5F2E5C5-E573-4BD2-A550-A7F83D5BFE73Q26785313-8EAAA5D9-F12A-479F-BB72-094F132EF2AFQ28545914-09DAA744-B6C5-441A-8596-0A884CB45308Q30591171-8710E989-B937-4075-8E38-845B794542AFQ31168175-F4AF6012-8274-48A2-B74B-9BB8E59974F0Q33796083-C98F69F4-11CC-44CD-B86F-DAA61BC742B5Q34474159-B8FD73FA-8D18-4B57-B338-75062F400DE4Q34712017-83CC26DB-49AF-4ADA-84E7-41AF9314879AQ34735778-76D581B6-74FF-43DB-A68C-6770A6C1E375Q34786493-4DF1261E-5BAF-40CB-94AA-A73C2959E27EQ34786547-27F268AD-B7BC-452E-BE2B-43FA1EEEC9F8Q34974493-8539928D-2D0A-477A-8F46-EE40F3E7D0D4Q35363067-750FE0B0-C5AE-404F-91A8-9FB8D4DB7066Q35836668-EE6CD5E4-3208-4B37-8E14-E23A40A1C150Q36157482-CD60D79E-694E-4AC4-8D59-565EB031CB43Q36190983-4A26658F-BEF7-4B1D-94E8-193625D57ED2Q36200545-21D703E7-8704-467C-A917-593394CC62C1Q36228258-8E109DEE-EBAD-47E0-A971-12923E555E23Q36431066-EFF0A240-5F62-46AD-8D9C-0CC97FB38511Q36436720-11DA2696-67A8-40D6-9EEB-388007F2FD2FQ36545515-A5C08B5D-C2FF-49DE-A2E7-3F3E5F6269CAQ36791642-0EBAA819-7306-4464-A83B-2408BCEFAE3BQ37057268-7A7EFC1C-520E-461E-A5B6-1942530DD36EQ37139764-7370D078-A8EC-4F7B-BA87-79CE743B59B0Q37216710-C2EE9C9A-0FD4-43E0-B81C-5FDF77A5B9DFQ37457484-E2FF5DB8-C23A-420C-B7DA-9184CC07D4F8Q37645436-BC4915A8-A174-45CC-855F-CEB9A4C14BF7Q37690917-F287CF3C-E9BC-476C-B386-2C131991D800Q38308001-51173E4F-46EC-44C0-AA21-7D336E3780FEQ38801879-2317B107-4C2F-4C13-A453-C6F401C2DBEAQ38866652-1F329B7F-91DE-4F21-8455-AF45D541E085Q38983079-EB9A6ABF-4D16-47AD-94AB-496B98260335Q39231548-0087F965-9C28-4883-9276-61712CCA1DE4Q40565744-C4B5C263-FBC1-4AF5-AEC8-F9459B7D9A8AQ41282753-EEA53D3A-5E5F-4968-AC03-D1229FC7A99DQ41332703-E441B6E3-84C1-49A5-90B5-79DFA0258CC5Q41432736-1953F644-D70A-4976-9746-DBBC40462C1CQ41472140-06F4B3C2-EA3E-43CC-B1C8-785267218A26Q42015120-EC2D6C3C-2462-46C5-B8BF-ED63B360201C
P2860
VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
VEGF-A mRNA processing, stabil ...... he post-transcriptional level.
@en
VEGF-A mRNA processing, stabil ...... he post-transcriptional level.
@nl
type
label
VEGF-A mRNA processing, stabil ...... he post-transcriptional level.
@en
VEGF-A mRNA processing, stabil ...... he post-transcriptional level.
@nl
prefLabel
VEGF-A mRNA processing, stabil ...... he post-transcriptional level.
@en
VEGF-A mRNA processing, stabil ...... he post-transcriptional level.
@nl
P2093
P2860
P356
P1476
VEGF-A mRNA processing, stabil ...... he post-transcriptional level.
@en
P2093
Christian Touriol
Eric Lacazette
Hervé Prats
Stefania Millevoi
Tania Arcondéguy
P2860
P304
P356
10.1093/NAR/GKT539
P407
P577
2013-07-12T00:00:00Z
2013-09-01T00:00:00Z